• June 16-19, 2025
  • Boston Convention & Exhibition Center

Sessions

Loading

Forging New Pathways to Reimbursement for Digital Therapeutics: Considerations for Payer Coverage

Monday, June 03, 2024
Breakout Session
AI and Digital Health
24BC
Digital therapeutics present an evolution in healthcare technology by directly delivering software-based treatments and serving as tools for management and prevention, however, these developments face significant challenges in securing payer reimbursement. They offer innovative technologies that rely on mature data infrastructure and collection, and integrate AI to personalize treatments and content, they also generate opportunity and incentive for growth in innovative reimbursement arrangements across stakeholders, such as greater participation in value-based contracting. Panel participants will discuss the current reimbursement landscape for digital therapeutics and the implications for access. Further, the panel will discuss evidence evolution and coverage impact in digital therapeutics, systematic approaches and frameworks for evaluation, and the potential role of innovative value arrangements on the pathway to reimbursement.
Moderator
Brigit Kyei-Baffour
Principal
Avalere
Speakers
Jon Campbell, MS, PhD
Chief Science Officer
National Pharmaceutical Council
Dirk Soenksen
Co-founder and CEO
Ceresti Health
Beth Rogozinski
CEO
Oncoustics
Chris Koch
CEO
LeGen Medicial Devices
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS